Artivion | CRY - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Accuray USD 199.44M 4.83M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 106.93M 14.23M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Baxter International USD 3.59B 102M 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Integra LifeSciences USD 330.88M 15.96M 2026-06
J&J USD 54.9B 2.82B 2026-06
Mesa Laboratories USD 54.4M 6.1M 2025-12
Orthofix International USD 157.01M 4.02M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
ResMed USD 1.4B 43.9M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
Terumo JPY 413.28B 127.46B 2026-06
Trinity Biotech USD 141.21M 106.72M 2025-12